Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The Danish drugmaker aims to deliver more than 150 billion Danish crowns ($23 billion) in pipeline sales in 2035 and reach more than 60 million patients globally by 2030, CEO Mike Doustdar said. Shares fell as much as 9% as analysts questioned the company's pricing power and dealmaking strategy ahead of looming patent
CEO Mike Doustdar said at Novo Nordisk’s Capital Markets Day in London the company aims to launch more than five blockbuster drugs by 2030 and deliver more than 150 billion Danish crowns in pipeline sales in 2035.
Novo Nordisk aims to launch more than five blockbuster drugs by 2030 and to deliver more than 150 billion Danish crowns ($23 billion) in pipeline sales in 2035, its CEO Mike Doustdar said at a Capital Markets Day in London.